Bank of Montreal’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,163
Closed -$284K 4230
2022
Q1
$284K Sell
16,163
-15,433
-49% -$266K ﹤0.01% 3224
2021
Q4
$622K Buy
31,596
+1,112
+4% +$22.4K ﹤0.01% 2234
2021
Q3
$648K Buy
+30,484
New +$653K ﹤0.01% 2732
2020
Q4
Sell
-44,041
Closed -$792K 5019
2020
Q3
$792K Buy
+44,041
New +$789K ﹤0.01% 2089
2020
Q2
Sell
-46,388
Closed -$681K 4709
2020
Q1
$681K Buy
46,388
+2,522
+6% +$41.3K ﹤0.01% 1852
2019
Q4
$765K Sell
43,866
-5,799
-12% -$95.2K ﹤0.01% 2433
2019
Q3
$750K Buy
49,665
+15,670
+46% +$251K ﹤0.01% 2207
2019
Q2
$573K Buy
33,995
+7,442
+28% +$123K ﹤0.01% 2345
2019
Q1
$455K Buy
26,553
+24,072
+970% +$416K ﹤0.01% 2349
2018
Q4
$37K Sell
2,481
-11,291
-82% -$199K ﹤0.01% 3408
2018
Q3
$281K Buy
+13,772
New +$274K ﹤0.01% 2582
2015
Q3
Sell
-2,700
Closed -$76K 4064
2015
Q2
$76K Buy
+2,700
New +$74.8K ﹤0.01% 2853

Other funds holding HQL

Bank of Montreal's HQL Position: Q2 2022 in Review

Bank of Montreal sold out of abrdn Life Sciences Investors (HQL) in Q2 2022, closing a stake of 16,163 shares — an estimated $284K sold.

Bank of Montreal first reported a position in HQL in Q2 2015 and held it in 12 quarters. The position peaked at $792K in Q3 2020. 65 funds tracked by Wall St. Rank hold HQL as of Q2 2022.

  • Bank of Montreal reported no remaining abrdn Life Sciences Investors position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 16,163 abrdn Life Sciences Investors shares in Q2 2022, an estimated $284K.
  • Bank of Montreal first reported a position in abrdn Life Sciences Investors in Q2 2015 and held it in 12 quarters.
  • Bank of Montreal's abrdn Life Sciences Investors position peaked at $792K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.